Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

Sponsor
Nanjing Medical University
Study ID
NCT06730334
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.

Key Dates

First listed
Dec 12, 2024
Start date
Sep 1, 2023
Status verified
Dec 2024
Primary completion
Sep 1, 2026
Completion
Jun 1, 2028

Study Design

Enrollment
400 participants (estimated)

Primary Outcome Measure

Madrid Sonographic Enthesitis Index (MASEI) [ Time Frame: 12 weeks ]

Central Contacts

Find similar trials

Nationwide
Psoriatic arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies